Oscar Health Inc Financials
This page shows Oscar Health Inc (OSCR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
Oscar Health Inc has an operating margin of -3.4%, meaning the company retains $-3 of operating profit per $100 of revenue. This below-average margin results in a low score of 15/100, suggesting thin profitability after operating expenses. This is down from 0.6% the prior year.
Oscar Health Inc's revenue surged 27.5% year-over-year to $11.7B, reflecting rapid business expansion. This strong growth earns a score of 79/100.
Oscar Health Inc carries a low D/E ratio of 0.44, meaning only $0.44 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.
Oscar Health Inc's current ratio of 0.95 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 14/100, which could limit financial flexibility.
Oscar Health Inc has a free cash flow margin of 9.0%, earning a moderate score of 48/100. The company generates positive cash flow after capital investments, but with room for improvement.
Oscar Health Inc generates a -45.3% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from 2.5% the prior year.
Oscar Health Inc passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Oscar Health Inc generates $-2.47 in operating cash flow ($1.1B OCF vs -$443.2M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Oscar Health Inc earns $-22.5 in operating income for every $1 of interest expense (-$396.4M vs $17.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Oscar Health Inc generated $11.7B in revenue in fiscal year 2025. This represents an increase of 27.5% from the prior year.
Oscar Health Inc's EBITDA was -$367.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 511.0% from the prior year.
Oscar Health Inc reported -$443.2M in net income in fiscal year 2025. This represents a decrease of 1842.5% from the prior year.
Oscar Health Inc earned $-1.69 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1790.0% from the prior year.
Cash & Balance Sheet
Oscar Health Inc generated $1.1B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 11.4% from the prior year.
Oscar Health Inc held $2.8B in cash against $430.1M in long-term debt as of fiscal year 2025.
Margins & Returns
Oscar Health Inc's operating margin was -3.4% in fiscal year 2025, reflecting core business profitability. This is down 4.0 percentage points from the prior year.
Oscar Health Inc's net profit margin was -3.8% in fiscal year 2025, showing the share of revenue converted to profit. This is down 4.1 percentage points from the prior year.
Oscar Health Inc's ROE was -45.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 47.8 percentage points from the prior year.
Capital Allocation
Oscar Health Inc invested $36.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 30.4% from the prior year.
OSCR Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8B-6.1% | $3.0B+4.3% | $2.9B-6.0% | $3.0B+27.3% | $2.4B-1.3% | $2.4B+9.2% | $2.2B+3.6% | $2.1B |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $511.0M-2.0% | $521.6M-2.4% | $534.5M+10.7% | $482.8M+3.6% | $465.8M+1.2% | $460.4M+5.8% | $435.2M+10.4% | $394.2M |
| Operating Income | -$333.7M-158.2% | -$129.3M+43.9% | -$230.5M-177.6% | $297.1M+301.1% | -$147.7M-205.4% | -$48.4M-171.3% | $67.8M-63.5% | $185.6M |
| Interest Expense | -$1.1M-116.0% | $6.9M+17.3% | $5.8M-2.5% | $6.0M-0.5% | $6.0M+3.6% | $5.8M-2.9% | $6.0M+1.5% | $5.9M |
| Income Tax | -$247K+86.3% | -$1.8M+64.2% | -$5.0M-139.7% | $12.7M+3244.8% | -$404K-119.5% | $2.1M-55.2% | $4.6M+365.6% | $996K |
| Net Income | -$352.6M-156.5% | -$137.4M+39.8% | -$228.4M-183.0% | $275.3M+279.3% | -$153.5M-181.2% | -$54.6M-197.1% | $56.2M-68.3% | $177.4M |
| EPS (Diluted) | N/A | $-0.53+40.4% | $-0.89-196.7% | $0.92 | N/A | $-0.22-210.0% | $0.20-67.7% | $0.62 |
OSCR Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.3B+10.1% | $5.7B-10.0% | $6.4B+9.2% | $5.8B+20.7% | $4.8B+8.0% | $4.5B-10.4% | $5.0B+13.3% | $4.4B |
| Current Assets | $4.6B+22.6% | $3.8B-12.8% | $4.3B+14.3% | $3.8B+32.7% | $2.8B+20.1% | $2.4B-29.5% | $3.4B-4.1% | $3.5B |
| Cash & Equivalents | $2.8B+29.1% | $2.1B-17.3% | $2.6B+16.2% | $2.2B+46.4% | $1.5B+26.6% | $1.2B-46.8% | $2.3B+1.7% | $2.2B |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $5.3B+13.3% | $4.7B-9.6% | $5.2B+15.9% | $4.5B+17.9% | $3.8B+15.3% | $3.3B-14.2% | $3.9B+14.2% | $3.4B |
| Current Liabilities | $4.9B+22.3% | $4.0B-18.3% | $4.9B+17.3% | $4.1B+19.8% | $3.5B+17.2% | $3.0B-15.6% | $3.5B+16.0% | $3.0B |
| Long-Term Debt | $430.1M-37.3% | $686.3M+128.8% | $299.9M+0.1% | $299.7M+0.1% | $299.6M+0.1% | $299.4M+0.1% | $299.2M+0.1% | $299.0M |
| Total Equity | $977.6M-4.5% | $1.0B-11.6% | $1.2B-13.1% | $1.3B+31.5% | $1.0B-12.8% | $1.2B+2.2% | $1.1B+10.3% | $1.0B |
| Retained Earnings | -$3.3B-12.0% | -$2.9B-4.9% | -$2.8B-8.9% | -$2.6B+9.7% | -$2.9B-5.7% | -$2.7B-2.1% | -$2.6B+2.1% | -$2.7B |
OSCR Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $671.9M+169.7% | -$964.7M-289.5% | $509.1M-42.1% | $878.5M+153.3% | $346.8M+169.3% | -$500.1M-200.6% | $497.2M-21.6% | $634.4M |
| Capital Expenditures | $9.1M+0.6% | $9.0M-2.9% | $9.3M+2.8% | $9.0M+32.4% | $6.8M-9.9% | $7.6M+0.1% | $7.6M+27.1% | $6.0M |
| Free Cash Flow | $662.8M+168.1% | -$973.7M-294.8% | $499.8M-42.5% | $869.5M+155.7% | $340.0M+167.0% | -$507.7M-203.7% | $489.6M-22.1% | $628.4M |
| Investing Cash Flow | -$48.7M-132.5% | $150.1M+189.2% | -$168.2M+3.5% | -$174.2M-454.0% | -$31.4M+94.6% | -$577.8M-21.0% | -$477.6M-58.9% | -$300.6M |
| Financing Cash Flow | $8.2M-97.8% | $364.0M+1544.8% | $22.1M+354.2% | $4.9M+27.7% | $3.8M-79.4% | $18.6M-0.8% | $18.7M-31.5% | $27.3M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
OSCR Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -11.9%-7.6pp | -4.3%+3.7pp | -8.1%-17.8pp | 9.8%+15.9pp | -6.2%-4.2pp | -2.0%-5.1pp | 3.1%-5.6pp | 8.7% |
| Net Margin | -12.6%-8.0pp | -4.6%+3.4pp | -8.0%-17.0pp | 9.0%+15.5pp | -6.4%-4.2pp | -2.3%-4.8pp | 2.5%-5.8pp | 8.3% |
| Return on Equity | -36.1%-22.7pp | -13.4%+6.3pp | -19.7%-40.4pp | 20.6%+35.8pp | -15.2%-10.4pp | -4.7%-9.6pp | 4.9%-12.3pp | 17.2% |
| Return on Assets | -5.6%-3.2pp | -2.4%+1.2pp | -3.6%-8.3pp | 4.7%+7.9pp | -3.2%-1.9pp | -1.2%-2.3pp | 1.1%-2.9pp | 4.0% |
| Current Ratio | 0.950.0 | 0.95+0.1 | 0.89-0.0 | 0.91+0.1 | 0.82+0.0 | 0.80-0.2 | 0.96-0.2 | 1.16 |
| Debt-to-Equity | 0.44-0.2 | 0.67+0.4 | 0.26+0.0 | 0.22-0.1 | 0.30+0.0 | 0.260.0 | 0.26-0.0 | 0.29 |
| FCF Margin | 23.6%+56.2pp | -32.6%-50.1pp | 17.4%-11.1pp | 28.5%+14.3pp | 14.2%+35.2pp | -20.9%-43.0pp | 22.1%-7.3pp | 29.3% |
Note: The current ratio is below 1.0 (0.95), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Oscar Health Inc's annual revenue?
Oscar Health Inc (OSCR) reported $11.7B in total revenue for fiscal year 2025. This represents a 27.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Oscar Health Inc's revenue growing?
Oscar Health Inc (OSCR) revenue grew by 27.5% year-over-year, from $9.2B to $11.7B in fiscal year 2025.
Is Oscar Health Inc profitable?
No, Oscar Health Inc (OSCR) reported a net income of -$443.2M in fiscal year 2025, with a net profit margin of -3.8%.
What is Oscar Health Inc's EBITDA?
Oscar Health Inc (OSCR) had EBITDA of -$367.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Oscar Health Inc have?
As of fiscal year 2025, Oscar Health Inc (OSCR) had $2.8B in cash and equivalents against $430.1M in long-term debt.
What is Oscar Health Inc's operating margin?
Oscar Health Inc (OSCR) had an operating margin of -3.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Oscar Health Inc's net profit margin?
Oscar Health Inc (OSCR) had a net profit margin of -3.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Oscar Health Inc's return on equity (ROE)?
Oscar Health Inc (OSCR) has a return on equity of -45.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Oscar Health Inc's free cash flow?
Oscar Health Inc (OSCR) generated $1.1B in free cash flow during fiscal year 2025. This represents a 11.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Oscar Health Inc's operating cash flow?
Oscar Health Inc (OSCR) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Oscar Health Inc's total assets?
Oscar Health Inc (OSCR) had $6.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Oscar Health Inc's capital expenditures?
Oscar Health Inc (OSCR) invested $36.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Oscar Health Inc's current ratio?
Oscar Health Inc (OSCR) had a current ratio of 0.95 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Oscar Health Inc's debt-to-equity ratio?
Oscar Health Inc (OSCR) had a debt-to-equity ratio of 0.44 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Oscar Health Inc's return on assets (ROA)?
Oscar Health Inc (OSCR) had a return on assets of -7.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Oscar Health Inc's Piotroski F-Score?
Oscar Health Inc (OSCR) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Oscar Health Inc's earnings high quality?
Oscar Health Inc (OSCR) has an earnings quality ratio of -2.47x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Oscar Health Inc cover its interest payments?
Oscar Health Inc (OSCR) has an interest coverage ratio of -22.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Oscar Health Inc?
Oscar Health Inc (OSCR) scores 41 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.